NCT00683384已完成不适用
A Prospective, Observational Study to Monitor Safety in Patients Who Were Administered With Etanercept (Enbrel) 25 mg by Subcutaneous Injection
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 93 人开始时间: 2007年1月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 93
- 主要终点
- Number of Participants With Spontaneous Adverse Events Reported Until 30 Days After Each Injection
研究概览
简要总结
The purpose of this study is to collect post-marketing information on the safety of Enbrel in Filipino patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients from the study center who received or will receive at least one dose of Enbrel according to the approved product indication.
排除标准
- •Previously discontinued Enbrel therapy due to significant safety concern.
研究组 & 干预措施
1
干预措施: Etanercept (Enbrel) (Drug)
结局指标
主要结局
Number of Participants With Spontaneous Adverse Events Reported Until 30 Days After Each Injection
时间窗: 30 days post injection up to 3 years
次要结局
未报告次要终点
研究者
相似试验
终止
不适用
An Observational Study to Evaluate the Safety and Efficacy of Cetuximab in Combination With Platinum-based Chemotherapy in the First-line Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of Head and NeckCarcinoma, Squamous CellNCT01142869Merck KGaA, Darmstadt, Germany133
已完成
不适用
Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and ChildrenRheumatoid ArthritisNCT00484809Wyeth is now a wholly owned subsidiary of Pfizer100
已完成
不适用
Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)Complicated Skin and Skin Structure InfectionsComplicated Intra-abdominal InfectionsNCT00683332Pfizer621
招募中
不适用
An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac ArrhythmiasNCT04750798Biosense Webster, Inc.8,000
已完成
不适用
Post-Marketing Study of the Safety of Prevenar (Pneumococcal Conjugate Vaccine, 7-valent)Vaccines, Pneumococcal Conjugate VaccineNCT00683410Wyeth is now a wholly owned subsidiary of Pfizer3,366